IBS-C Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)

99S3857990
85 Pages
May 2020
Healthcare

Download Sample Get Discount

Summary

According to 99Strategy, the Global IBS-C Drugs Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global IBS-C Drugs market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

Catalent Pharmaceuticals Solutions

Nestle

Abbott Laboratories

Synergy Pharmaceuticals

Sucampo Pharmaceuticals

Novartis Pharma Ag

Astellas Pharmaceuticals

Ardelyx, Inc

Synthetic Biologics, Inc

Teva Pharmaceutical Industries

Bama-Geve, SLU

Ferring BV

Ironwood Pharmaceuticals, Inc

Salix Pharmaceuticals Ltd

Norgine B.V

Prometheus Laboratories Inc

Actavis Nordic A/S

Albireo Pharma Inc

Yuhan Corp

Astrazeneca Plc

The Menarini Group

Ono Pharmaceutical Co., Ltd

Key Product Type

Linaclotide

Lubiprostone

Osmotic Laxatives

Stimulant Laxatives

Others

Market by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Main Aspects covered in the Report

Overview of the IBS-C Drugs market including production, consumption, status & forecast and market growth

2016-2020 historical data and 2021-2026 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

Impact of Coronavirus on the Industry

Table of Content

1 Industrial Chain Overview

1.1 IBS-C Drugs Industry

1.1.1 Overview

Figure IBS-C Drugs Picture List

1.1.2 Characteristics of IBS-C Drugs

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 Linaclotide

1.3.2 Lubiprostone

1.3.3 Osmotic Laxatives

1.3.4 Stimulant Laxatives

1.3.5 Others

1.4 End-Use List

1.4.1 Demand in Hospital Pharmacies

1.4.2 Demand in Retail Pharmacies

1.4.3 Demand in Online Pharmacies

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2016-2026

Figure Global Market Size and Forecast with Growth Rate, 2016-2026

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2016-2026

Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2016-2026

Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2016-2026

Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

Figure Global Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume

Figure Global Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD

2.1.2 Global Consumption

Figure Global Market Volume and Growth Rate, 2016-2020, in Volume

Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume

Figure Global Market Amount and Growth Rate, 2016-2020, in Million USD

Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

Figure Asia-Pacific Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.2 North America

Figure North America Production Volume Status and Growth Rate, 2016-2020, in Volume

Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure North America Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.3 South America

Figure South America Production Volume Status and Growth Rate, 2016-2020, in Volume

Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure South America Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.4 Europe

Figure Europe Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Europe Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.5 Middle East & Africa

Figure Middle East & Africa Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.2 Consumption

2.2.2.1 Asia-Pacific

Figure Asia-Pacific Market Volume and Growth Rate, 2016-2020, in Volume

Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2016-2020, in Million USD

Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.2 North America

Figure North America Market Volume and Growth Rate, 2016-2020, in Volume

Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure North America Market Amount and Growth Rate, 2016-2020, in Million USD

Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.3 South America

Figure South America Market Volume and Growth Rate, 2016-2020, in Volume

Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure South America Market Amount and Growth Rate, 2016-2020, in Million USD

Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.4 Europe

Figure Europe Market Volume and Growth Rate, 2016-2020, in Volume

Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Europe Market Amount and Growth Rate, 2016-2020, in Million USD

Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.5 Middle East & Africa

Figure Middle East & Africa Market Volume and Growth Rate, 2016-2020, in Volume

Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2016-2020, in Million USD

Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2018

3.2 Manufacturers List

3.2.1 Catalent Pharmaceuticals Solutions Overview

Table Catalent Pharmaceuticals Solutions Overview List

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Catalent Pharmaceuticals Solutions (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 Nestle Overview

Table Nestle Overview List

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Nestle (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 Abbott Laboratories Overview

Table Abbott Laboratories Overview List

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Abbott Laboratories (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 Synergy Pharmaceuticals Overview

Table Synergy Pharmaceuticals Overview List

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Synergy Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 Sucampo Pharmaceuticals Overview

Table Sucampo Pharmaceuticals Overview List

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Sucampo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Novartis Pharma Ag Overview

Table Novartis Pharma Ag Overview List

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Novartis Pharma Ag (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Astellas Pharmaceuticals Overview

Table Astellas Pharmaceuticals Overview List

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Astellas Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 Ardelyx, Inc Overview

Table Ardelyx, Inc Overview List

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Ardelyx, Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 Synthetic Biologics, Inc Overview

Table Synthetic Biologics, Inc Overview List

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Synthetic Biologics, Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 Teva Pharmaceutical Industries Overview

Table Teva Pharmaceutical Industries Overview List

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Teva Pharmaceutical Industries (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 Bama-Geve, SLU Overview

Table Bama-Geve, SLU Overview List

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Bama-Geve, SLU (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Ferring BV Overview

Table Ferring BV Overview List

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Ferring BV (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 Ironwood Pharmaceuticals, Inc Overview

Table Ironwood Pharmaceuticals, Inc Overview List

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Ironwood Pharmaceuticals, Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 Salix Pharmaceuticals Ltd Overview

Table Salix Pharmaceuticals Ltd Overview List

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Salix Pharmaceuticals Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Norgine B.V Overview

Table Norgine B.V Overview List

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Norgine B.V (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Prometheus Laboratories Inc Overview

Table Prometheus Laboratories Inc Overview List

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Prometheus Laboratories Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 Actavis Nordic A/S Overview

Table Actavis Nordic A/S Overview List

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Actavis Nordic A/S (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

3.2.18 Albireo Pharma Inc Overview

Table Albireo Pharma Inc Overview List

3.2.18.1 Product Specifications

3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Albireo Pharma Inc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.18.3 Recent Developments

3.2.18.4 Future Strategic Planning

3.2.19 Yuhan Corp Overview

Table Yuhan Corp Overview List

3.2.19.1 Product Specifications

3.2.19.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Yuhan Corp (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.19.3 Recent Developments

3.2.19.4 Future Strategic Planning

3.2.20 Astrazeneca Plc Overview

Table Astrazeneca Plc Overview List

3.2.20.1 Product Specifications

3.2.20.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Astrazeneca Plc (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.20.3 Recent Developments

3.2.20.4 Future Strategic Planning

3.2.21 The Menarini Group Overview

Table The Menarini Group Overview List

3.2.21.1 Product Specifications

3.2.21.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of The Menarini Group (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.21.3 Recent Developments

3.2.21.4 Future Strategic Planning

3.2.22 Ono Pharmaceutical Co., Ltd Overview

Table Ono Pharmaceutical Co., Ltd Overview List

3.2.22.1 Product Specifications

3.2.22.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table IBS-C Drugs Business Operation of Ono Pharmaceutical Co., Ltd (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.22.3 Recent Developments

3.2.22.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

Figure Global Market Size and Growth Rate, 2016-2020, in Volume

Figure Global Market Size and Growth Rate, 2016-2020, in Million USD

Figure Global Competition Sketch Overview

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

Table Global Production Volume List by Manufacturers, 2016-2020, in Volume

Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume

Figure Global Production Volume Share by Manufacturers in 2020, in Volume

Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD

Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD

Figure Global Production Amount Share by Manufacturers in 2020, in Million USD

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume

5.2 Segment Subdivision by Product Type

5.2.1 Market in Linaclotide

5.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Linaclotide , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Linaclotide , 2016-2020, in Volume

5.2.1.2 Situation & Development

5.2.2 Market in Lubiprostone

5.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Lubiprostone , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Lubiprostone , 2016-2020, in Volume

5.2.2.2 Situation & Development

5.2.3 Market in Osmotic Laxatives

5.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Osmotic Laxatives , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Osmotic Laxatives , 2016-2020, in Volume

5.2.3.2 Situation & Development

5.2.4 Market in Stimulant Laxatives

5.2.4.1 Market Size

Figure Global Market Amount and Growth Rate in Stimulant Laxatives , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Stimulant Laxatives , 2016-2020, in Volume

5.2.4.2 Situation & Development

5.2.5 Market in Others

5.2.5.1 Market Size

Figure Global Market Amount and Growth Rate in Others, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2016-2020, in Volume

5.2.5.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume

6.2 Segment Subdivision

6.2.1 Market in Hospital Pharmacies

6.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Hospital Pharmacies , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Hospital Pharmacies , 2016-2020, in Volume

6.2.1.2 Situation & Development

6.2.2 Market in Retail Pharmacies

6.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Retail Pharmacies , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Retail Pharmacies , 2016-2020, in Volume

6.2.2.2 Situation & Development

6.2.3 Market in Online Pharmacies

6.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Online Pharmacies, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Online Pharmacies, 2016-2020, in Volume

6.2.3.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

Table Global Market Forecast by Region Segment 2021-2026, in Million USD

Table Global Market Forecast by Region Segment 2021-2026, in Volume

7.2 Consumption Forecast

7.2.1 Product Type Forecast

Table Global Market Amount by Product Type Segment 2021-2026, in Million USD

Table Global Market Volume by Product Type Segment 2021-2026, in Volume

7.2.2 End-Use Forecast

Table Global Market Amount by End-Use Segment 2021-2026, in Million USD

Table Global Market Volume by End-Use Segment 2021-2026, in Volume

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

Figure Cost Component Ratio

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

9.3 Impact of Coronavirus on the IBS-C Drugs Industry

9.3.1 Impact on Industry Upstream

9.3.2 Impact on Industry Downstream

9.3.3 Impact on Industry Channels

9.3.4 Impact on Industry Competition

9.3.5 Impact on Industry Employment

10 Research Conclusion

List of Table